Aurinia Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Edmonton, Alberta, Canada
SEC filing record 1 source field available
Fiscal year end
31 December
Aurinia Pharmaceuticals Inc. has filed 613 SEC EDGAR filings since 28 Feb 2014

SEC filing history

Showing 351-375 of 613 matching filings.

Per page
25
Current page
15
SUPPL File 333-238785

PROSPECTUS SUPPLEMENT NO. 2

Filing date
22 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
22 Jul 2020
Reporting date
22 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
21 Jul 2020
Reporting date
21 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SUPPL File 333-238785

PROSPECTUS SUPPLEMENT NO. 1

Filing date
26 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
22 Jun 2020
Reporting date
22 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-238785

EFFECT filing

Filing date
19 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-10/A File 333-238785

AMENDMENT NO. 1 TO FORM F-10

Filing date
17 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-239048

S-8

Filing date
09 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
09 Jun 2020
Reporting date
09 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
05 Jun 2020
Reporting date
05 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
03 Jun 2020
Reporting date
03 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
F-X File 333-238785

F-X

Filing date
29 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-10 File 333-238785

FORM F-10

Filing date
29 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
26 May 2020
Reporting date
25 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

6-K

Filing date
14 May 2020
Reporting date
31 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
14 May 2020
Reporting date
14 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

6-K

Filing date
28 Apr 2020
Reporting date
31 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
27 Apr 2020
Reporting date
27 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
20 Apr 2020
Reporting date
20 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
19 Mar 2020
Reporting date
18 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
17 Mar 2020
Reporting date
17 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
16 Mar 2020
Reporting date
16 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
12 Mar 2020
Reporting date
12 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
05 Mar 2020
Reporting date
05 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .